CN102271760B - 放射装置 - Google Patents
放射装置 Download PDFInfo
- Publication number
- CN102271760B CN102271760B CN200980153667.2A CN200980153667A CN102271760B CN 102271760 B CN102271760 B CN 102271760B CN 200980153667 A CN200980153667 A CN 200980153667A CN 102271760 B CN102271760 B CN 102271760B
- Authority
- CN
- China
- Prior art keywords
- housing
- treatment
- treatment surface
- light
- lamp system
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002428 photodynamic therapy Methods 0.000 claims abstract description 43
- 238000011282 treatment Methods 0.000 claims description 139
- 239000000203 mixture Substances 0.000 claims description 54
- 230000005855 radiation Effects 0.000 claims description 28
- 239000003504 photosensitizing agent Substances 0.000 claims description 27
- 238000003780 insertion Methods 0.000 claims description 25
- 230000037431 insertion Effects 0.000 claims description 25
- 239000002243 precursor Substances 0.000 claims description 24
- 239000003814 drug Substances 0.000 claims description 21
- 229940079593 drug Drugs 0.000 claims description 19
- -1 5-ALA ester Chemical class 0.000 claims description 18
- 210000003679 cervix uteri Anatomy 0.000 claims description 15
- 239000000463 material Substances 0.000 claims description 12
- 210000001215 vagina Anatomy 0.000 claims description 12
- 150000003839 salts Chemical class 0.000 claims description 6
- 239000012780 transparent material Substances 0.000 claims description 6
- 230000007246 mechanism Effects 0.000 claims description 3
- 230000001105 regulatory effect Effects 0.000 claims description 2
- 239000013013 elastic material Substances 0.000 claims 1
- 230000001960 triggered effect Effects 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 abstract description 7
- ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical compound NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 description 22
- 150000001875 compounds Chemical class 0.000 description 21
- 229960002749 aminolevulinic acid Drugs 0.000 description 19
- 238000012377 drug delivery Methods 0.000 description 18
- 238000000034 method Methods 0.000 description 18
- 125000000217 alkyl group Chemical group 0.000 description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 14
- 125000003118 aryl group Chemical group 0.000 description 13
- 238000009472 formulation Methods 0.000 description 11
- 206010008342 Cervix carcinoma Diseases 0.000 description 10
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 10
- 201000010881 cervical cancer Diseases 0.000 description 10
- 201000010099 disease Diseases 0.000 description 10
- 241000701806 Human papillomavirus Species 0.000 description 9
- 230000006870 function Effects 0.000 description 8
- 238000005286 illumination Methods 0.000 description 8
- 206010028980 Neoplasm Diseases 0.000 description 7
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 7
- 125000004432 carbon atom Chemical group C* 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 229920001296 polysiloxane Polymers 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 6
- 229910052760 oxygen Inorganic materials 0.000 description 6
- 239000001301 oxygen Substances 0.000 description 6
- 150000004032 porphyrins Chemical class 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 125000001424 substituent group Chemical group 0.000 description 6
- 230000005856 abnormality Effects 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 210000005002 female reproductive tract Anatomy 0.000 description 5
- 229920006395 saturated elastomer Polymers 0.000 description 5
- 238000009825 accumulation Methods 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 125000001309 chloro group Chemical class Cl* 0.000 description 4
- 208000035475 disorder Diseases 0.000 description 4
- 230000003902 lesion Effects 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 210000000664 rectum Anatomy 0.000 description 4
- 125000000547 substituted alkyl group Chemical group 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 101150070189 CIN3 gene Proteins 0.000 description 3
- 235000014676 Phragmites communis Nutrition 0.000 description 3
- 208000009621 actinic keratosis Diseases 0.000 description 3
- 125000003545 alkoxy group Chemical group 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 101150005988 cin2 gene Proteins 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 239000013536 elastomeric material Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 125000006283 4-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Cl)C([H])([H])* 0.000 description 2
- 125000002528 4-isopropyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])*)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 125000006181 4-methyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])C([H])([H])* 0.000 description 2
- 101150061050 CIN1 gene Proteins 0.000 description 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- 208000009608 Papillomavirus Infections Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 235000017168 chlorine Nutrition 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000010410 dusting Methods 0.000 description 2
- 125000001153 fluoro group Chemical group F* 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 210000004392 genitalia Anatomy 0.000 description 2
- 125000005842 heteroatom Chemical group 0.000 description 2
- 150000003840 hydrochlorides Chemical class 0.000 description 2
- 230000036512 infertility Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 229940118199 levulan Drugs 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- 230000036210 malignancy Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- YUUAYBAIHCDHHD-UHFFFAOYSA-N methyl 5-aminolevulinate Chemical group COC(=O)CCC(=O)CN YUUAYBAIHCDHHD-UHFFFAOYSA-N 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 230000009826 neoplastic cell growth Effects 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 125000006503 p-nitrobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1[N+]([O-])=O)C([H])([H])* 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 230000037081 physical activity Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000001959 radiotherapy Methods 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 1
- 125000006218 1-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004847 2-fluorobenzyl group Chemical group [H]C1=C([H])C(F)=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 125000006179 2-methyl benzyl group Chemical group [H]C1=C([H])C(=C(C([H])=C1[H])C([H])([H])*)C([H])([H])[H] 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000006284 3-fluorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C(F)=C1[H])C([H])([H])* 0.000 description 1
- 125000006180 3-methyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C(=C1[H])C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000004176 4-fluorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1F)C([H])([H])* 0.000 description 1
- 125000004217 4-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C([H])([H])* 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 206010059313 Anogenital warts Diseases 0.000 description 1
- 206010004146 Basal cell carcinoma Diseases 0.000 description 1
- KSFOVUSSGSKXFI-GAQDCDSVSA-N CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O Chemical compound CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O KSFOVUSSGSKXFI-GAQDCDSVSA-N 0.000 description 1
- 208000000907 Condylomata Acuminata Diseases 0.000 description 1
- 206010058314 Dysplasia Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 229910014689 LiMnO Inorganic materials 0.000 description 1
- HBBGRARXTFLTSG-UHFFFAOYSA-N Lithium ion Chemical compound [Li+] HBBGRARXTFLTSG-UHFFFAOYSA-N 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 206010034972 Photosensitivity reaction Diseases 0.000 description 1
- 208000006994 Precancerous Conditions Diseases 0.000 description 1
- 208000005107 Premature Birth Diseases 0.000 description 1
- 206010036590 Premature baby Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 125000004423 acyloxy group Chemical group 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000005194 alkoxycarbonyloxy group Chemical group 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 208000025009 anogenital human papillomavirus infection Diseases 0.000 description 1
- 201000004201 anogenital venereal wart Diseases 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 239000012635 anticancer drug combination Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 238000003782 apoptosis assay Methods 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000000746 body region Anatomy 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 1
- 229960004316 cisplatin Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000002573 colposcopy Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 230000002254 contraceptive effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000012502 diagnostic product Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 125000003963 dichloro group Chemical group Cl* 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 238000003487 electrochemical reaction Methods 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 150000008282 halocarbons Chemical group 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000009802 hysterectomy Methods 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 125000002346 iodo group Chemical group I* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000012145 laser resection Methods 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229910001416 lithium ion Inorganic materials 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000001700 mitochondrial membrane Anatomy 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000000955 neuroendocrine Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000004789 organ system Anatomy 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 238000013021 overheating Methods 0.000 description 1
- 125000004043 oxo group Chemical group O=* 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229940124531 pharmaceutical excipient Drugs 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 208000007578 phototoxic dermatitis Diseases 0.000 description 1
- 231100000018 phototoxicity Toxicity 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- 230000005522 programmed cell death Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 229950003776 protoporphyrin Drugs 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 229910052717 sulfur Chemical group 0.000 description 1
- 239000011593 sulfur Chemical group 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000000287 tissue oxygenation Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 125000004417 unsaturated alkyl group Chemical group 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0082—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
- A61B5/0084—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for introduction into the body, e.g. by catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0061—5-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
- A61N5/0603—Apparatus for use inside the body for treatment of body cavities
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/062—Photodynamic therapy, i.e. excitation of an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
- A61N5/0603—Apparatus for use inside the body for treatment of body cavities
- A61N2005/0608—Rectum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
- A61N5/0603—Apparatus for use inside the body for treatment of body cavities
- A61N2005/0611—Vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0626—Monitoring, verifying, controlling systems and methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
- A61N2005/0645—Applicators worn by the patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/065—Light sources therefor
- A61N2005/0651—Diodes
- A61N2005/0652—Arrays of diodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pathology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Radiology & Medical Imaging (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Emergency Medicine (AREA)
- Physics & Mathematics (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- High Energy & Nuclear Physics (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Optics & Photonics (AREA)
- Otolaryngology (AREA)
- Radiation-Therapy Devices (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (17)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610325680.3A CN106039580B (zh) | 2009-01-12 | 2009-12-16 | 放射装置、套件和混合物 |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0900461.5 | 2009-01-12 | ||
GB0900461A GB0900461D0 (en) | 2009-01-12 | 2009-01-12 | Photodynamic therapy device |
GB0916666A GB0916666D0 (en) | 2009-01-12 | 2009-09-22 | Photodynamic therapy device |
GB0916666.1 | 2009-09-22 | ||
PCT/EP2009/009037 WO2010078929A1 (en) | 2009-01-12 | 2009-12-16 | Irradiation device |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610325680.3A Division CN106039580B (zh) | 2009-01-12 | 2009-12-16 | 放射装置、套件和混合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102271760A CN102271760A (zh) | 2011-12-07 |
CN102271760B true CN102271760B (zh) | 2016-06-15 |
Family
ID=40379469
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200980153667.2A Active CN102271760B (zh) | 2009-01-12 | 2009-12-16 | 放射装置 |
CN201610325680.3A Active CN106039580B (zh) | 2009-01-12 | 2009-12-16 | 放射装置、套件和混合物 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610325680.3A Active CN106039580B (zh) | 2009-01-12 | 2009-12-16 | 放射装置、套件和混合物 |
Country Status (22)
Country | Link |
---|---|
US (4) | US20110295186A1 (zh) |
EP (2) | EP2545962B1 (zh) |
JP (1) | JP5697603B2 (zh) |
KR (1) | KR101714092B1 (zh) |
CN (2) | CN102271760B (zh) |
AU (1) | AU2009336871B2 (zh) |
BR (1) | BRPI0923955B1 (zh) |
CA (1) | CA2748144C (zh) |
DK (2) | DK2545962T3 (zh) |
ES (2) | ES2552662T3 (zh) |
GB (2) | GB0900461D0 (zh) |
HK (2) | HK1164191A1 (zh) |
HU (1) | HUE028003T2 (zh) |
MX (1) | MX2011007377A (zh) |
NZ (1) | NZ593894A (zh) |
PL (2) | PL2382009T3 (zh) |
PT (2) | PT2382009E (zh) |
RU (2) | RU2619790C2 (zh) |
SG (2) | SG172028A1 (zh) |
SI (1) | SI2545962T1 (zh) |
WO (1) | WO2010078929A1 (zh) |
ZA (1) | ZA201104660B (zh) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2763923C (en) | 2009-06-11 | 2016-09-13 | Photocure Asa | Semi-solid compositions comprising 5-ala esters |
WO2011107478A1 (en) | 2010-03-01 | 2011-09-09 | Photocure Asa | Cosmetic compositions |
ES2620780T3 (es) * | 2010-07-09 | 2017-06-29 | Photocure Asa | Dispositivos que contienen composiciones secas para su uso en terapia fotodinámica |
WO2012103380A1 (en) * | 2011-01-27 | 2012-08-02 | Nitto Denko Corporation | Phototherapy devices and methods comprising optionally substituted terphenyl and quaterphenyl compounds |
ITRN20110014A1 (it) * | 2011-02-25 | 2011-05-27 | M & T Srl | Dispositivio di irradiazione luminosa della superficie interna di organi |
RU2615870C2 (ru) * | 2011-12-19 | 2017-04-11 | ФотоКьюэр АСА | Устройство облучения |
US9550072B2 (en) * | 2012-08-03 | 2017-01-24 | Cerca Solutions, LLC | Diagnostic device, therapeutic device, and uses thereof |
US20140067024A1 (en) * | 2012-08-30 | 2014-03-06 | Photocure Asa | Dual panel photodynamic therapy lamp |
KR101425722B1 (ko) * | 2012-11-01 | 2014-08-01 | 홍지인 | 광역학 다중파장 질염 치료 장치 |
USD750269S1 (en) | 2013-04-09 | 2016-02-23 | Photocure Asa | Light treatment apparatus |
GB201306369D0 (en) * | 2013-04-09 | 2013-05-22 | Photocure As | Irradiation device |
GB2517707B (en) | 2013-08-28 | 2020-09-02 | Pci Biotech As | A device for light-induced rupture of endocytic vesicles to effect the delivery of an antigen |
US10004918B2 (en) * | 2014-07-03 | 2018-06-26 | Gregg Alan Klang | LED based vaginal light therapy device |
RU2609995C2 (ru) * | 2015-07-28 | 2017-02-07 | Владимир Анатольевич Дуванский | Способ фотодинамической терапии фоновых и предраковых заболеваний шейки матки |
CA3027560A1 (en) | 2016-06-17 | 2017-12-21 | Gensight Biologics | Device for illuminating an object with a controlled light intensity and associated method |
US11251635B2 (en) | 2017-12-19 | 2022-02-15 | Welch Allyn, Inc. | Vital signs monitor with a removable and dischargable battery |
WO2019123581A1 (ja) * | 2017-12-20 | 2019-06-27 | 公立大学法人 名古屋市立大学 | 紫外線照射装置、紫外線照射装置に用いられるアタッチメント及び弾性部材、並びに紫外線照射方法 |
RU181756U1 (ru) * | 2018-04-16 | 2018-07-26 | Азат Раимович Гильфанов | Устройство для фотодинамической фотосенсибилизирующей терапии |
EP4349401A1 (en) | 2019-02-13 | 2024-04-10 | Alpheus Medical, Inc. | Non-invasive sonodynamic therapy |
US11944842B2 (en) * | 2019-12-20 | 2024-04-02 | Gyrus Acmi, Inc. | Photodynamic therapy device and methods of use |
EP4138997A4 (en) * | 2020-04-20 | 2024-04-24 | Cern Corp. | VAGINAL LIGHT THERAPY DEVICES AND METHODS OF USE THEREOF |
EP4281178A1 (de) * | 2021-01-22 | 2023-11-29 | MEDLight GmbH | Penisring |
DE102022201337A1 (de) | 2022-02-09 | 2023-08-10 | Richard Wolf Gmbh | Bestrahlungsvorrichtung für die photodynamische Therapie |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE29611520U1 (de) * | 1996-07-02 | 1996-09-05 | Wilden, Lutz, Dr.med., 94051 Hauzenberg | Elektrischer Vaginalapplikator |
EP1138349B1 (en) * | 2000-03-23 | 2004-09-15 | Photo Therapeutics Limited | Therapeutic light source |
DE102006001736A1 (de) * | 2006-01-13 | 2007-07-26 | Margull, Matthias, Dipl.-Ing. | Vorrichtung zur Applikation von monochromatischem Licht in Körperöffnungen |
Family Cites Families (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5810067A (ja) | 1981-07-09 | 1983-01-20 | オリンパス光学工業株式会社 | 医療用カプセル |
US4858624A (en) * | 1988-02-24 | 1989-08-22 | Vance Products Incorporated D/B/A/ Cook Urological Incorporated And Cook Ob/Gyn | Device and method for intravaginal, barrier-type prevention of conception and infection |
IT1255984B (it) | 1991-12-27 | 1995-11-17 | Fabio Marchesi | Dispositivo per la disinfezione o la immunizzazione di zone del corpo umano esposte al contagio, da germi, batteri e virus |
US5445608A (en) * | 1993-08-16 | 1995-08-29 | James C. Chen | Method and apparatus for providing light-activated therapy |
IL108772A0 (en) * | 1994-02-24 | 1994-05-30 | Amcor Ltd | Treatment of rhinitis by biostimulative illumination |
WO1996023543A1 (en) | 1995-01-30 | 1996-08-08 | Angiomedics Ii Incorporated | Photolytic drug delivery systems |
US5674239A (en) * | 1995-02-21 | 1997-10-07 | Zadini; Filiberto P. | Intravaginal balloon for blood leakage prevention |
ES2157424T3 (es) | 1995-03-10 | 2001-08-16 | Photocure Asa | Esteres de acido 5-aminolevulinico como agentes fotosensibilizantes en fotoquimioterapia. |
RU2512U1 (ru) * | 1995-06-16 | 1996-08-16 | Научный центр сердечно-сосудистой хирургии РАМН | Светодиодное устройство для фотодинамической терапии |
US5827186A (en) | 1997-04-11 | 1998-10-27 | Light Sciences Limited Partnership | Method and PDT probe for minimizing CT and MRI image artifacts |
US5974239A (en) * | 1997-06-11 | 1999-10-26 | Micron Electronics, Inc. | Data transfer method for a bus device in a computer system by placing first and second addresses corresponding to a bridge and with the bus device respectively on a bus |
GB9721506D0 (en) | 1997-10-10 | 1997-12-10 | Virulite Limited | Treatment of diseases |
GB0010686D0 (en) | 2000-05-03 | 2000-06-28 | Zinn Shiri | Stimulatory device |
US6551346B2 (en) * | 2000-05-17 | 2003-04-22 | Kent Crossley | Method and apparatus to prevent infections |
GB0018527D0 (en) * | 2000-07-27 | 2000-09-13 | Photocure Asa | Composition |
GB0018528D0 (en) | 2000-07-27 | 2000-09-13 | Photocure Asa | Compounds |
US6622049B2 (en) | 2000-10-16 | 2003-09-16 | Remon Medical Technologies Ltd. | Miniature implantable illuminator for photodynamic therapy |
US7107996B2 (en) * | 2001-04-10 | 2006-09-19 | Ganz Robert A | Apparatus and method for treating atherosclerotic vascular disease through light sterilization |
GB0118251D0 (en) * | 2001-07-26 | 2001-09-19 | Photocure Asa | Method |
US20040043349A1 (en) * | 2002-08-27 | 2004-03-04 | Chu-Yuan Liao | Illuminated mouthpiece |
US7252677B2 (en) | 2003-03-14 | 2007-08-07 | Light Sciences Oncology, Inc. | Light generating device to intravascular use |
US7144247B2 (en) * | 2003-04-25 | 2006-12-05 | Oralum, Llc | Hygienic treatments of structures in body cavities |
CN2624847Y (zh) * | 2003-07-18 | 2004-07-14 | 黄益富 | 一种激光低频腔道振动、按摩治疗头 |
US20050085455A1 (en) * | 2003-10-16 | 2005-04-21 | Light Sciences Corporation | Photodynamic therapy for local adipocyte reduction |
US7135034B2 (en) | 2003-11-14 | 2006-11-14 | Lumerx, Inc. | Flexible array |
GB0406917D0 (en) * | 2004-03-26 | 2004-04-28 | Photocure Asa | Compounds |
US20050239018A1 (en) * | 2004-04-27 | 2005-10-27 | Scott Green | Intraoral bite spacer and illumination apparatus |
GB0424833D0 (en) | 2004-11-10 | 2004-12-15 | Photocure Asa | Method |
US7384403B2 (en) | 2004-12-17 | 2008-06-10 | Depuy Products, Inc. | Wireless communication system for transmitting information from a medical device |
EP1871476B1 (en) * | 2005-03-31 | 2018-01-03 | Esther Mayer | Probe device for photobiomodulation of tissue lining a body cavity |
US20070260231A1 (en) | 2005-04-21 | 2007-11-08 | Ondine International, Ltd. | Optical probe for delivery of light |
US20060293645A1 (en) * | 2005-06-22 | 2006-12-28 | Hibner Michael C | Transilluminating rod used at laparoscopic hysterectomy |
US7559945B2 (en) * | 2006-01-13 | 2009-07-14 | Clarimedix Inc. | Multi-spectral photon therapy device and methods of use |
GB0608315D0 (en) | 2006-04-27 | 2006-06-07 | Univ St Andrews | Light emitting device for use in therapeutic and/or cosmetic treatment |
CN101432044A (zh) * | 2006-04-28 | 2009-05-13 | 恩迪尼国际有限公司 | 光消毒装置和方法 |
US8021148B2 (en) * | 2006-05-03 | 2011-09-20 | Forsyth Dental Infirmary For Children | Intraoral light-emitting device |
US8057464B2 (en) * | 2006-05-03 | 2011-11-15 | Light Sciences Oncology, Inc. | Light transmission system for photoreactive therapy |
US8088122B2 (en) | 2006-08-17 | 2012-01-03 | George Y. Choi | Optical ear infection treatment device and method |
US8292935B2 (en) | 2006-09-12 | 2012-10-23 | Bistitec Pharma Marketing Ltd | Photonic device and method for treating cervical dysplasia |
GB0700580D0 (en) * | 2007-01-11 | 2007-02-21 | Photocure Asa | Use |
JP5133735B2 (ja) * | 2007-03-27 | 2013-01-30 | ヤーマン株式会社 | 美容処理装置 |
CN101293124B (zh) * | 2007-04-29 | 2010-09-08 | 曾世一 | 一种***光照装置 |
CN201055611Y (zh) * | 2007-08-24 | 2008-05-07 | 李贵列 | 女性生殖器官远红外负离子保健理疗器 |
GB0816027D0 (en) | 2008-09-03 | 2008-10-08 | Lumicure Ltd | Controlled light emitting apparatus |
US20130053657A1 (en) * | 2009-09-28 | 2013-02-28 | Illuminare Holdings Ltd. | Intravaginal monitoring device and network |
GB201306369D0 (en) * | 2013-04-09 | 2013-05-22 | Photocure As | Irradiation device |
-
2009
- 2009-01-12 GB GB0900461A patent/GB0900461D0/en not_active Ceased
- 2009-09-22 GB GB0916666A patent/GB0916666D0/en not_active Ceased
- 2009-12-16 PT PT09801405T patent/PT2382009E/pt unknown
- 2009-12-16 CN CN200980153667.2A patent/CN102271760B/zh active Active
- 2009-12-16 PT PT121884217T patent/PT2545962E/pt unknown
- 2009-12-16 PL PL09801405T patent/PL2382009T3/pl unknown
- 2009-12-16 ES ES12188421.7T patent/ES2552662T3/es active Active
- 2009-12-16 NZ NZ593894A patent/NZ593894A/en unknown
- 2009-12-16 AU AU2009336871A patent/AU2009336871B2/en active Active
- 2009-12-16 KR KR1020117015567A patent/KR101714092B1/ko active IP Right Grant
- 2009-12-16 ES ES09801405T patent/ES2398197T3/es active Active
- 2009-12-16 RU RU2013114432A patent/RU2619790C2/ru active
- 2009-12-16 HU HUE12188421A patent/HUE028003T2/en unknown
- 2009-12-16 CN CN201610325680.3A patent/CN106039580B/zh active Active
- 2009-12-16 MX MX2011007377A patent/MX2011007377A/es active IP Right Grant
- 2009-12-16 WO PCT/EP2009/009037 patent/WO2010078929A1/en active Application Filing
- 2009-12-16 DK DK12188421.7T patent/DK2545962T3/en active
- 2009-12-16 JP JP2011544801A patent/JP5697603B2/ja active Active
- 2009-12-16 PL PL12188421T patent/PL2545962T3/pl unknown
- 2009-12-16 SG SG2011041761A patent/SG172028A1/en unknown
- 2009-12-16 EP EP12188421.7A patent/EP2545962B1/en active Active
- 2009-12-16 SI SI200931312T patent/SI2545962T1/sl unknown
- 2009-12-16 DK DK09801405.3T patent/DK2382009T3/da active
- 2009-12-16 US US13/144,222 patent/US20110295186A1/en not_active Abandoned
- 2009-12-16 EP EP09801405A patent/EP2382009B1/en active Active
- 2009-12-16 BR BRPI0923955-3A patent/BRPI0923955B1/pt active IP Right Grant
- 2009-12-16 CA CA2748144A patent/CA2748144C/en active Active
- 2009-12-16 RU RU2011122954/14A patent/RU2487740C2/ru not_active IP Right Cessation
- 2009-12-16 SG SG10201508271PA patent/SG10201508271PA/en unknown
-
2011
- 2011-06-23 ZA ZA2011/04660A patent/ZA201104660B/en unknown
-
2012
- 2012-05-15 HK HK12104766.0A patent/HK1164191A1/zh unknown
- 2012-08-27 US US13/595,167 patent/US20120330219A1/en not_active Abandoned
-
2015
- 2015-04-30 US US14/700,501 patent/US20150231407A1/en not_active Abandoned
-
2016
- 2016-11-28 US US15/362,112 patent/US10874875B2/en active Active
- 2016-12-05 HK HK16113854A patent/HK1225676A1/zh unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE29611520U1 (de) * | 1996-07-02 | 1996-09-05 | Wilden, Lutz, Dr.med., 94051 Hauzenberg | Elektrischer Vaginalapplikator |
EP1138349B1 (en) * | 2000-03-23 | 2004-09-15 | Photo Therapeutics Limited | Therapeutic light source |
DE102006001736A1 (de) * | 2006-01-13 | 2007-07-26 | Margull, Matthias, Dipl.-Ing. | Vorrichtung zur Applikation von monochromatischem Licht in Körperöffnungen |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102271760B (zh) | 放射装置 | |
US10485985B2 (en) | Irradiation device | |
KR102057349B1 (ko) | 광 조사 기구 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1164191 Country of ref document: HK |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1164191 Country of ref document: HK |
|
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20111207 Assignee: Yahong medical technology ( cayman ) Ltd. Assignor: PHOTOCURE ASA Contract record no.: X2021990000181 Denomination of invention: Radiation device Granted publication date: 20160615 License type: Exclusive License Record date: 20210406 |
|
EE01 | Entry into force of recordation of patent licensing contract |